Austin Rolling, Gabriella Rowe, and Aaron Knape are this week's Houston innovators to know. Photos courtesy

In this weekly roundup of Houston innovators, we find an entrepreneur who created the tech solution he wished he'd had as a salesman, an innovation leader with big goals for The Ion, and a startup founder who's in for a very busy March.

Here are this week's Houston innovators to know.

Austin Rolling, CEO and co-founder of Outfield

austin rolling

Photo courtesy of Outfield

As an experienced salesman, Austin Rolling knows the challenges salespeople face on a daily basis. Rolling, who worked in a number of positions in both inside and outside sales with such big name companies as Whirlpool and Beats by Dre. He tells InnovationMap about how he wished he had better tools for communication and keeping organized.

"Fast forward some years later, my co-founder and I decided to work on a solution that could help support outside sales agents and I was able to use my domain expertise as an outside sales rep to ID the realm of solutions for various customer segments," Rolling says.

Rolling runs Outfield, a Houston-based software company gives field reps an intuitive interface to manage their territory and accounts on-the-go as well as instantly communicate with the rest of their team effortlessly across all devices. Click here to read more.

Gabriella Rowe, executive director of The Ion

Courtesy of Station Houston

Now that Station Houston has merged with Capital Factory, Gabriella Rowe, who previously served Station as CEO, has completely transitioned into her role as executive director of The Ion. On last week's episode of the Houston Innovators Podcast, Rowe discussed the merger and how her goal for The Ion is to make the facility a vehicle for innovation development, but also create a diverse and inclusive environment reflective of Houston's own diversity.

"We're creating an opportunity for Houstonians," Rowe says on the episode, explaining why she's focused on bringing in a wide range of programming and education into The Ion.

In the episode, Rowe also discusses the Ion Smart Cities Accelerators, which has 10 companies from its inaugural cohort in pilot mode across Houston and has launched applications for its second cohort, as well as why she thinks Houston's innovation ecosystem is sure to succeed this time around. Click here to read more and stream the podcast.

Aaron Knape, co-founder and CEO of sEATz

Courtesy of sEATz

Like most lifelong Houstonians, Aaron Knape has a long history with the Houston Livestock Show and Rodeo. But this season, he'll be involved in a whole new way. Knape's startup, sEATz, an in-seat delivery app, will be live in certain sections of the rodeo at NRG Stadium.

"It's really great to be able to be a part of the rodeo as far as a provider to help enhance that experience in the stadium," Knape says. "It goes back to our model of we want to serve a venue and the fans in that venue — not necessarily a specific sport or concert."

SEATz had a busy football season, servicing the likes of The Texans, the University of Houston Cougars, and more, but turns out, football is not over. Through its partnership with Delaware North, the food and beverage provider for UH's TDECU Stadium, sEATz has added the XFL's Houston Roughnecks fans to its roster of users. Click here to read more.

Houston-based Outfield, a sales management app, wants to gamify the sales process for its users. Photo via outfieldapp.com

Growing Houston startup is gamifying professional sales with management tools for sellers

Always be gaming

Actor Alec Baldwin's "always be closing" monologue is not only the most popular scene in David Mamet's 1992 film, "Glengarry Glen Ross," it has become the unofficial mantra for sales professionals worldwide.

While that ABC line, the art of persuasion and strong product offerings are necessary pillars in sales, the ability to centralize data and foster accountability, productivity and drive revenue is just as vital. That's where Outfield, a web and mobile-based CRM, comes in. The app specializes in data driven revenue and efficiency solutions for companies with a burgeoning outside sales force.

"Outfield is a software solution designed specifically to support organizations to drive revenue, generate efficiencies and build operational structures via outside sales, field marketing efforts and field merchandising efforts," says Austin Rolling, CEO and co-founder of Outfield.

"For example, the merchandising that seen in a grocery store where sales reps are taking pictures of displays, dropping off marketing collateral, setting up demos and setting up tastings, those are the types of programs where individuals will likely use our software solutions in order to manage their workflow operations," Rolling adds.

How it works

Outfield's selling point revolves around helping organizations discover valuable insights about their market vertical, track and verify their sales team's activity and manage their field operations.

Simply put, it gives field reps an intuitive interface to manage their territory and accounts on-the-go as well as instantly communicate with the rest of their team effortlessly across all devices.

Outfield makes it easier for sales teams to keep track of projects and clients. Photo via outfieldapp.com

"Prior to starting Outfield, I worked in a number of sales positions, both outside and inside sales positions," says Rolling, who worked in sales with such big name companies as Whirlpool and Beats by Dre. "When I was in outside sales, I was always underwhelmed with the amount of support and solutions we were provided while we were out in the field. I always knew there was an opportunity there because the tools that we had were lacking in terms of capabilities.

"Fast forward some years later, my co-founder and I decided to work on a solution that could help support outside sales agents and I was able to use my domain expertise as an outside sales rep to ID the realm of solutions for various customer segments."

Rolling founded Outfield with co-founder Adam Steele in 2015 and operates out of The Cannon, an entrepreneurial co-working space specifically designed to house Houston-based startups and small businesses.

Management tools for sellers

The company began as a solution for a nutraceutical and supplement company called Cellucor.

Cellucor needed an efficient way to manage its legion of outside sales reps, which were servicing stores like Vitamin Shoppe and GNC where they worked with the in-store representatives to promote their brand products.

The company also wanted to track the whereabouts of its sales reps, monitor their touch points in the field and centralize the teams' reports and call forms.

"Sales reps are able to manage their relationships and interactions with their customers through the tool," says Rolling. "We can also integrate with our customers' inside sales tool if they have one. We can send our data over to other systems. It depends on whether or not the system that we are looking to integrate with actually has an open API that we can transmit data from our system to theirs.

"In terms of sales numbers and touch points that you have with customers, there's a report that outside sales reps need to fill out while out in the field. They can record all of the information then sync that data into the cloud, so the sales manager or sales director can see all of that data from the web-based version of Outfield."

Rolling's intimate understanding of the needs of outside sales reps and knowledge of the industry vertical has been immeasurable in growing Outfield's client base, which has expanded to over 200 customers in 75 countries.

Gamifying sales

Over the next five years, the burgeoning startup plans to build on its momentum as a disruptor in the space by incubating and releasing a new suite of products that will ultimately have a number of synergies with Outfield.

The most pressing product is League Play, a built-in game for salespeople within the Outfield CRM platform that allows sales reps the opportunity to compete and collaborate with one another similar to popular video games such as MLB The Show 20 or NBA 2K20.

"League Play essentially allows reps to build reputations of being star performers based on their utilization and activity of their Outfield account," says Rolling. "They're able to leverage that data and this will be good for comparison purposes for upper management. Therefore, if a sales manager or sales director wants to know who their star player is, they can go into League Play see how their sales reps are performing. We designed it to be very reminiscent of sports."

The tool has leaderboards and signature player cards, which is similar to Topps baseball cards. The player cards features the sales reps' profile, including all of the statistics of their individual performance and offer attributes.

"Like Madden, you can go in and see how their ratings are," says Rolling. "This is something that's going to be groundbreaking. This is something that has not been done before. The idea is to be sales as a sport to take advantage of sales reps' competitive nature. It should boost their overall productivity, which managers should be able to reap the benefits of, while reps will be able to build their own brand and personal reputation. It's a great way to boost performance overall."

All sales reps that utilize Outfield will be automatically entered into League Play. While the platform allows sales reps the chance to feel like they're athletes, it also helps them build reputations for themselves as top tier sales professionals and give them more of a vested interest in utilizing the application.

Moving forward, Outfield wants to further permeate the market in its widespread use of advanced analytics with the help of artificial intelligence and machine learning.

"We want to be able to think about KPI's and metrics that can tell the story of outside sales in a very specific way," says Rolling. "We think that we can infuse and generate an appetite for people who want to think more intelligently about their go-to-market activities because one thing we're learning and know for sure is that our customers aren't getting less competitive, they're getting more competitive."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.